Applications of [[2-(6-Amino-9H-Purin-9-Yl)Ethoxy]Methyl]Phosphonic Acid Diethyl Ester in Industrial Manufacturing

This page details verified industrial applications for [[2-(6-Amino-9H-Purin-9-Yl)Ethoxy]Methyl]Phosphonic Acid Diethyl Ester, emphasizing its functional roles in regulated segments. We draw on production data and downstream feedback to outline where this compound sees practical, large-scale use, and specify industry standards, usage levels, integration points, and resulting goods for each sector.

1. Antiviral Active Pharmaceutical Ingredient Synthesis

[[2-(6-Amino-9H-Purin-9-Yl)Ethoxy]Methyl]Phosphonic Acid Diethyl Ester functions as a crucial phosphonate precursor in the synthesis of nucleotide analogue pharmaceuticals. Its unique structure supports selective phosphorylation reactions fundamental to the creation of active antiviral APIs in the antiretroviral and hepatitis medication segments. Pharmaceutical manufacturers utilize this intermediate for its reactivity under controlled synthesis conditions, allowing for high-purity conversion into final actives with strict impurity profiles.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) Monograph Standards
• US Pharmacopeia (USP) requirements for antiviral APIs
• FDA 21 CFR 211 - Finished Pharmaceuticals cGMPs

Typical usage ratio

• 0.8–1.2 molar equivalents relative to purine base substrates depending on batch scale and required conversion yield

Downstream process integration

• Added post-activation in the phosphorylation reaction step enabling phosphonate group transfer to nucleoside scaffolds
• Used during the coupling phase between the protected purine core and aliphatic phosphonate linker

Final product types

• Tenofovir intermediates
• Other nucleotide analog antiviral APIs
• Bulk pharmaceutical intermediates for further downstream formulation

2. Custom Synthesis of Prodrug Phosphonate Intermediates

Downstream specialty synthesis companies employ this compound for the manufacture of advanced phosphonate ester intermediates, which serve as prodrug precursors in several investigational and generic medicinal chemistry programs. These phosphonate esters improve targeted delivery and pharmacokinetics in modified prodrug architectures, enabling precise control of hydrolysis rates and bioactivation profiles during scale-up or pilot production.

Industry compliance standards

• Good Laboratory Practice (GLP) for nonclinical safety studies (OECD Principles)
• ISO 9001:2015 Quality Management Systems for chemical synthesis
• REACH Registration for chemical safety compliance in the EU
• Hazardous Substance Control: OSHA 29 CFR 1910 (where applicable)

Typical usage ratio

• Employed at 1.05–1.3 molar ratio relative to core nucleoside alcohols, adjusted based on reaction yield optimization and downstream requirements

Downstream process integration

• Charged into the alkylation stage for production of phosphonate-ester modified active intermediates
• Incorporated during the late-stage step in solution-phase synthesis prior to purification

Final product types

• Prodrug pharmaceutical intermediates (e.g., phosphonate ester variations for improved bioavailability)
• Reference standards for biological testing
• Regulatory submission samples for drug master files

3. Synthesis of Molecular Probes for Life Science Research

Research reagent suppliers use this phosphonic acid diethyl ester as a modular building block in the preparation of phosphorylated and tagged oligonucleotide probes. Such applications demand consistency in structural configuration and purity, especially for probes destined for use in enzyme assays, cell imaging, and molecular diagnostics platforms where precise phosphonate incorporation impacts activity and detection thresholds.

Industry compliance standards

• ISO 13485:2016 for Medical Devices (applicable for diagnostic reagents)
• EN ISO 9001 certified analytical chemical manufacturing
• Good Documentation Practice (GDP) for reagent traceability
• Applicable local biosafety and hazardous handling regulations

Typical usage ratio

• Utilized at 0.9–1.1 equivalents per nucleotide probe scaffold, fine-tuned for coupling efficiency and probe length

Downstream process integration

• Introduced at the phosphitylation or functionalization step during probe chain elongation
• Blended with other protected nucleotide analogues in automated or manual solid/liquid-phase synthesis procedures

Final product types

• Labeled oligonucleotide probes for PCR and qPCR diagnostics
• Fluorescent and biotinylated molecular beacons
• Enzyme substrate analogues for research kits

4. Manufacture of Solid-State Nucleotide Derivative Agents

Solid-phase synthesis platforms in the pharmaceutical and biotechnology sectors incorporate this compound as a stable phosphonate donor in resin-bound to solution-phase transitions. Its robust ester functionality accommodates batch and continuous processes for the efficient attachment of phosphonates onto solid matrices, which support subsequent deprotection and functionalization steps prevalent in mass production settings.

Industry compliance standards

• ICH Q9 Quality Risk Management for pharmaceutical manufacturing
• GMP Part II (EU) for API and intermediate synthesis
• ISO 14644 Cleanroom Standards (applies to solid-phase manufacturing sites)
• Environmental, Health, and Safety (EHS) standards for scale-up procedures

Typical usage ratio

• Typically charged at 0.8–1.1 equivalents based on resin loading capacity and desired phosphonate substitution level; variations depend on matrix material and scalability

Downstream process integration

• Employed immediately following activation of polymeric resins in solid-phase reactors
• Used during column loading and wash cycles to ensure thorough phosphonate transfer before elution

Final product types

• Resin-bound nucleotide precursors for chemical libraries
• Bulk nucleotide derivative substances for later release and conversion
• Protected phosphonate building blocks for combinatorial chemistry